The sample was collected by the ITA under the Testing Authority of the International Olympic Committee (IOC) during an in-competition anti-doping control on 6 August 2021 in Tokyo, Japan, following the final of the Men’s 4 x 100m Relay Final of the Olympic Games Tokyo 2020. The result was reported by the WADA-accredited laboratory of Tokyo on 8 August 2021.
The athlete has the right to request the analysis of the B-sample. If requested by the athlete and if the B-sample analysis confirms the AAF, or alternatively if the athlete does not wish to have the B-sample analysis undertaken, the case will be referred to the Anti-Doping Division of the Court of Arbitration for Sport (CAS ADD) for adjudication under the IOC Anti-Doping Rules applicable to the Olympic Games Tokyo 2020 (IOC ADR).
The CAS ADD will consider the matter of the finding of an Anti-Doping Rule Violation (ADRV) and the disqualification of the Men’s 4 x 100 Relay results of the British team. In this regard, pursuant to the IOC ADR and the World Athletics Anti-Doping Rules: ‘where the athlete who has committed an Anti-Doping Rule Violation competed as a member of a relay team, the relay team shall be automatically disqualified from the Event in question, with all resulting consequences for the relay team, including the forfeiture of all titles, awards, medals, points and prize and appearance money’.
Once the matter is settled under the IOC ADR, the case will be referred to the Athletics Integrity Unit (World Athletics) to follow up on sanctions beyond the Olympic Games Tokyo 2020. Given that the case is underway, there will be no further comments during the ongoing proceeding.
• This media release was published by the International Testing Agency (ITA) on 12 August 2021. Click here for the original.